Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0

Ronald Boellaard, M. J. OʼDoherty, Wolfgang Weber et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 1.3K citations · Full text

Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?

Ulrike Leiter, Petra Buettner, Thomas Eigentler et al. · Melanoma Research · 2010 · 58 citations

Survival Benefit, Surgical Oncology, Prognosis +19

Costs of the detection of metastases and follow-up examinations in cutaneous melanoma

Ulrike Leiter, Ashfaq A. Marghoob, Konstantinos Lasithiotakis et al. · Melanoma Research · 2009 · 52 citations

Surgical Oncology, Blood Tests, Abdomen Sonography +17

Serum S100β Protein as a Marker of Disease Activity in Patients with Malignant Melanoma

Spyros Retsas, M. Q. Mohammed, H. Abraha et al. · Medical Oncology · 2001 · 52 citations

Tumor Biology, Biomarker (Medicine), Medicine +11

Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse

Friederike Egberts, Wolfgang N. Hitschler, Michael Weichenthal et al. · Melanoma Research · 2009 · 49 citations

Pathology, Prospective Monitoring, Dermatology +17